Xi’an investor research is strongest when it connects technical ambition with the next commercial proof point. A scientific founder should compare locally grounded hard-tech routes with national specialists, while keeping research support and direct investment separate.
Compare 15 routes by connection, stage and sector, then use the worked example and copyable worksheet to build a more useful first research wave.
Choose a Xi’an investor by commercialization needs
| Your situation | Research first | Prepare or clarify |
|---|---|---|
| An early hard-tech company needs a specialist first conversation | Casstar, Ivy, Linear or Vertex China | Technical evidence, founder capability and a credible product application |
| The company needs a Xi’an direct-investment vehicle | Xi’an Caijin’s relevant technology fund | The exact vehicle, direct-company criteria and local project connection |
| A company is researching the High-Tech Zone investment ecosystem | Capitech / Xi Gao Tou | Reconciled manager identity and current round or submission route |
| A developed technology business needs growth capital | The relevant Qiming, Legend or SCGC strategy | Commercial maturity and the particular fund’s entry point |
Choose a small first wave you can research well. Save one current, source-backed reason for fit and one question to resolve for each investor. The aim is a better next conversation, not the longest possible spreadsheet.
Compare 15 investor routes
This is a selective, unranked comparison of investment organizations and clearly identified investor networks. Local connection, country focus and investment eligibility are different facts. The wider names are not all Xi'an offices. On a small screen, scroll the table sideways to compare columns.
| Investor or network | Connection | Stage distinction | Company focus |
|---|---|---|---|
| Casstar | Local connection: Xi’an and Beijing dual headquarters | Early stage | Hard technology and scientific commercialization |
| Xi’an Caijin investment family | Local connection: Xi’an-local investment and industrial-development platform | Angel and other technology vehicles; fund-specific | Scientific commercialization; hard technology; future industries |
| Xi’an High-Tech Venture Capital / Capitech | Local connection: Xi’an High-Tech Zone investment ecosystem | Technology venture investment; current entry round to confirm | Technology and industrial innovation |
| Ivy Capital | Wider-market mandate: Founded in Shanghai with Shanghai and Hong Kong context | Early investment with follow-on activity | AI infrastructure; advanced materials; photonics; other deep technology |
| Linear Capital | Wider-market mandate: China-linked technology investor with international examples | Angel through Series A | AI software and hardware; science and manufacturing |
| Vertex Ventures China | Wider-market mandate: China team with Beijing, Shanghai and Shenzhen offices | Early-stage investments; fund-specific | Technology; advanced manufacturing; biomedicine |
| Qiming Venture Partners | Wider-market mandate: China venture investment platform | Early and growth stages | Technology and healthcare innovation |
| Soul Capital | Wider-market mandate: Explicit China-focused early-stage strategy | Early stage | Technology startups |
| Jingwei Venture Capital | Wider-market mandate: China-focused strategy in its Chinese-language overview | Early and early-growth stages | Software; technology; advanced manufacturing; consumer |
| Lighthouse Yuanzhan Capital | Wider-market mandate: China-based manager with China and US startup activity | Early stage | Technology products and commercialization |
| Legend Capital | Wider-market mandate: Shenzhen office | Early venture and growth strategies differ | Technology; enterprise; manufacturing; health and other themes |
| Shenzhen Capital Group | Wider-market mandate: Shenzhen base; nationwide investment network | Early and growth VC/PE strategies differ | Information technology; advanced manufacturing; healthcare; materials; energy |
| Sinovation Ventures | Wider-market mandate: China technology platform; USD and RMB vehicles | Strategy-specific venture; confirm entry round | Technology and innovation |
| ZhenFund | Wider-market mandate: Beijing-rooted founder and technology ecosystem | Early stage | Technology across sectors |
| MiraclePlus | Wider-market mandate: Early-stage accelerator for startups in China | Early-stage investing accelerator; Beijing cohort commitment | Startup and technology companies |
Why does Xi’an hard-tech fundraising need a commercialization map?
A technical achievement is the start of the business story, not the entire story. Casstar’s published model connects research, early investment and company development. Xi’an Caijin publishes several direct technology-investment vehicles alongside its allocator and broader financial activities.
Map the step from research to a product, then from a product to customer adoption. The investor should be relevant to the next unresolved step. A company proving technical feasibility and one financing production capacity should not use the same outreach brief.
Which Xi’an investor names can create duplicate leads?
Casstar and its Xike Angel-related vehicles are one family in this comparison. Capitech and Xi Gao Tou naming variants should also be reconciled. For Xi’an Caijin, identify the specific direct-investment vehicle but keep one manager-level relationship record.
The point is not to minimize the ecosystem. It is to prevent a spreadsheet from overstating the number of independent decisions available. Distinct strategies can be tracked under the same organization, with one clear outreach owner and separate questions for each vehicle.
What should an early scientific founder share first?
Start with the problem, the technical evidence you can share, the intended customer and the next validation milestone. Explain where the company is already operating and which research or industrial relationships are established facts.
Do not substitute a university, lab or district association for commercial evidence. Use the official business-plan or company-contact route where one is published. If the initial round or founder form is unspecified, ask before sending detailed technical or financial documents.
15 investors and networks to research
1. Casstar
Early hard-technology venture investor. Casstar links early hard-technology investment with research commercialization and company-building support. Its Xi’an base makes it a locally grounded research route for scientific founders. Prepare technical validation and a credible customer use case, and count Casstar and its Xike Angel-related vehicles as one investment family.
Public approach: Use the business-plan submission destination on the official contact page. Official source. Published approach or contact route.
2. Xi’an Caijin investment family
Municipal direct-equity and venture-fund platform. Xi’an Caijin distinguishes government fund management from named direct-investment vehicles, including science-and-technology angel, hard-technology angel and future-industry funds. Ask which vehicle can invest in the company itself. The municipal fund of funds, leasing arm and guarantee businesses are not additional equity investors.
Public approach: Use the official company contact to identify a direct-investment fund. Official source. Published approach or contact route.
3. Xi’an High-Tech Venture Capital / Capitech
Technology venture manager. The Xi’an High-Tech Zone’s 2026 reporting identifies the manager’s continuing private-equity and venture-capital activity. Capitech and Xi Gao Tou naming variants should be reconciled before outreach. Use current team confirmation for an initial round or application route rather than relying on an old portfolio investment.
Public approach: Identify the manager through the official district and industry-association profile; no open pitch form was confirmed. Official source.
4. Ivy Capital
Deep-technology venture investor. Ivy states an AI and deep-tech focus. Explain the technical evidence and commercial use case, then confirm the company's geographic and fund fit.
Public approach: Official investment information. Official source.
5. Linear Capital
Frontier-technology venture investor. Linear describes angel-to-Series-A investment and a frontier-technology focus. A past international portfolio company does not establish that every geography or company structure is eligible.
Public approach: Official investment information. Official source.
6. Vertex Ventures China
China venture fund team. Vertex describes independently operated regional fund teams. Select the China team and current vehicle rather than assuming every Vertex fund shares the same mandate.
Public approach: Official investment information. Official source.
7. Qiming Venture Partners
Venture investment manager. Qiming's Chinese-language overview distinguishes technology and healthcare. Match the actual product and stage to the relevant team instead of assuming a portfolio company's later round defines initial entry.
Public approach: Official investment information. Official source.
8. Soul Capital
Early-stage venture investor. Soul's official English overview describes early-stage technology companies in China. Prepare the technical differentiation and the operating market before asking about the current vehicle.
Public approach: Official investment information. Official source.
9. Jingwei Venture Capital
China venture investment manager. Jingwei's official overview describes early and early-growth investing in China. Confirm the relevant investment team and current route; historical brand associations are not separate investors.
Public approach: Official investment information. Official source.
10. Lighthouse Yuanzhan Capital
Early-stage venture investor. This is Lighthouse Yuanzhan Capital, not similarly named firms in other markets. Its published approach connects technology with commercialization; verify the current fund and founder route.
Public approach: Official investment information. Official source.
11. Legend Capital
Venture and growth private-equity manager. Legend’s current site separates early venture from growth private equity and publishes several sector strategies. Identify the company’s actual stage, sector and relevant team before approaching the manager. Fundraising into a fund and a company seeking investment are different enquiries.
Public approach: Use official team/contact information; do not assume an LP contact is a company pitch route. Official source.
12. Shenzhen Capital Group
Venture and private-capital manager. SCGC’s current overview emphasizes venture capital and hard technology across China. A company seeking equity should identify the direct-investment team rather than its fund-of-funds, public-market or other asset activities. Government-related fund commitments are not extra startup investors in this list.
Public approach: Use the current official team/contact route. Official source.
13. Sinovation Ventures
Technology venture firm. Sinovation is a wider China technology route for a Beijing company. A founder should identify the current team, vehicle and entry stage, then explain the product and business evidence. Its investment, portfolio support and fund-investor enquiries are separate activities.
Public approach: Use the current official company/team contact. Official source.
14. ZhenFund
Early-stage venture firm. ZhenFund’s current About page states an early-stage founder thesis and publishes a BP submission address. Explain the team’s insight and what the product has established. The investment route is distinct from the firm’s media, events and recruiting enquiries.
Public approach: Use the published BP route, not media contact. Official source.
15. MiraclePlus
Investment-backed accelerator. MiraclePlus combines early-stage equity investment with an accelerator for startups in China. Its published model asks admitted teams to join a three-month program in Beijing. That is a different commitment from working with an investor near home. Check current cohort timing and terms; mentors and demo-day investors are not additional committed funders.
Public approach: Official accelerator information. Official source.
Worked example: a Xi’an scientific-instrument company
Fictional worked example. A fictional team has validated a scientific instrument in a laboratory and wants to test it with an industrial customer. It needs a defined customer evaluation, not a general promise of global scale. The first research wave should include hard-tech specialists and the relevant local direct-investment route.
| Candidate lane | Next action | Why it changes the decision |
|---|---|---|
| Casstar | Explain the research-to-company path and the intended customer use | The manager publishes a specific early hard-tech focus |
| Xi’an Caijin | Ask which direct vehicle matches the present development stage | A municipal fund of funds is not the same as direct founder capital |
| National hard-tech managers | Show technical differentiation and the next adoption test | A city connection alone does not establish venture fit |
Keep the round tied to a concrete next milestone. Use the round-size planning worksheet to organize assumptions before committing to an outreach target.
Build your Xi'an investor-fit worksheet
Use one card per investment family and strategy. The worksheet works in a document, spreadsheet or your Finta research notes. Separate verified facts, assumptions and unanswered questions so the next action is clear.
INVESTOR FIT CARD: XI'AN
Company and next funding milestone: [authorized company facts]
Research-to-product milestone: [what is proven; what remains]
Investor family / naming variants: [one relationship record]
Xi’an operating or industrial connection: [verified facts only]
Investor family and specific vehicle: [current name; avoid duplicates]
Official stage, sector and geography: [source URL and research date]
Fit evidence: [what actually matches the company today]
Mismatch or unresolved question: [what remains unknown]
Investor role: [lead / participant / unknown; source or direct confirmation]
Approach: [public founder route / company contact / permitted introduction]
Relationship context: [known person; permission to ask; no assumed introduction]
Owner, next action and follow-up date: [person; task; date]Bring the shortlist into Finta to connect investor research, relationship context, conversations and follow-up. Aurora can help organize the context and prepare the next steps for your review. You stay in control of the approach and information shared.
Review the shortlist with Aurora, Claude or Codex
Use public sources and company information you are authorized to share. Check the output against those sources before acting.
Help me build an evidence-backed investor shortlist for a Xi'an startup.
Company, location, current evidence and next funding milestone: [authorized facts]
Candidates and official sources: [names, URLs and research dates]
Separate local presence, country focus, regional mandate and actual company eligibility.
Check the current investment family, vehicle, entry stage, sector and public founder route.
Distinguish equity investors, angel networks, investing accelerators, grants, lending and services.
Do not infer current eligibility from an old portfolio investment or a nearby office.
Return a table: investor, fit evidence, mismatch, unknown, next question and action owner.
Suggest a small first research wave and explain exclusions.
Keep missing or contradictory facts as unknown; do not invent check sizes or lead behavior.
Do not contact anyone, submit applications or share confidential information.Connect the shortlist to the rest of your raise
For a broader starting point, see Venture Capital Firms in China: 18 Investors and Funding Routes. Then connect the research to your pre-seed preparation, the Seed Fundraising Comprehensive Guide and the investor-prospecting workflow.
Keep one owner and a clear next step for each investor conversation. A well-researched shortlist becomes valuable when source evidence, the right relationship context and thoughtful follow-through stay connected.
Methodology and research date
By Finta Editorial Team. Official investor and institutional materials reviewed 2026-11-13. This guide includes 15 investment families or clearly identified investor networks. It is not a ranking of returns, popularity or likelihood of funding.
Names, investment roles and stated strategies were checked against official materials linked in the profiles. Related vehicles and rebrands are grouped conservatively. A local connection, a wider investment mandate and company eligibility are different facts. Where an initial stage, current vehicle or intake is unspecified, it remains a question for the investor.
The Startup Genome ecosystem research helps frame the city opportunity; an ecosystem ranking or profile is not investor eligibility evidence. The cover is an editorial ecosystem illustration, not a map of investor offices or actual financing flows.
What is kept separate:
- Casstar / Xike-related vehicles are not counted as separate independent investors.
- Xi’an Caijin’s allocator, leasing and guarantee activities are not additional venture funds.
- An old portfolio investment does not establish a manager’s current entry stage or open application process.
General educational information, not a personal investment recommendation. Confirm the current company and fund requirements before approaching an investor.